The CNODES network of researchers, trainees, and analysts conduct studies using administrative healthcare data in response to queries from Canadian regulators. The results of these studies are published in open-access academic journals. CNODES also publishes a selection of its methodological advances, knowledge translation initiatives, and trainee projects.

Guertin JR, Rahme E, LeLorier J. Use of Continuous Exposure Variables when Examining Dose-Dependent Pharmacological Effects – Application to the Association between Exposure to Higher Statin Doses and the Incidence of Diabetes. J Popul Ther Clin Pharmacol. 2017 Jan 1; 24(1):5-15.

Schuster T, Lowe W, Platt RW. Propensity score model over-fitting leads to inflated variance of estimated odds ratios. Journal of Clinical Epidemiology. Journal of Clinical Epidemiology. J Clin Epidemiol. 2016 Dec;80:97-106.

Guertin JR, Rahme E, LeLorier J. Performance of the high-dimensional propensity score in adjusting for unmeasured confounders. Eur J Clin Pharmacol. 2016 Dec;72(12):1497-1505.

Tascilar K, Azoulay A, Dell’Aniello S, Bartels DB, Suissa S. The use of telmisartan and the incidence of cancer. Am J Hyperten. 2016 Dec 1;29(12):1358-1365.

Platt RW. On Designs for Vaccine Surveillance. Drug Saf. 2016 Dec;39(12):1161-1162.

Filion KB. Proton pump inhibitors and community acquired pneumonia: The observed link is probably due to protopathic bias and confounding by indication. BMJ 2016 Nov 17; 355:i6041. [Invited Editorial]

Tascilar K, Dell’Aniello S, Hudson M, Suissa S. Statins and Risk of Rheumatoid Arthritis – A Nested Case-Control Study. Arthritis Rheumatol. 2016 Nov;68(11):2603-2611.

Pang M, Schuster T, Filion KB, Schnitzer M, Eberg M, Platt RW. Effect Estimation in Point-exposure Studies with Binary Outcomes and High-dimensional Covariate Data – a comparison of Targeted Maximum Likelihood Estimation and Inverse Probability of Treatment Weighting. Int J Biostat. 2016 Nov 1;12(2).

Lian Y, Yin H, Pollak MN, Carrier S, Platt RW, Suissa S, Azoulay L. Phosphodiesterase Type 5 Inhibitors and the Risk of Melanoma Skin Cancer. Eur Urol. 2016 Nov;70(5):808-815.

Hicks BM, Yin H, Yu OH, Pollak MN, Platt RW, Azoulay L. Glucagon-like peptide-1 analogues and risk of breast cancer in women with type 2 diabetes: population based cohort study using the UK Clinical Practice Research Datalink. BMJ. 2016 Oct 20;355:i5340.